Vanguard Group’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-608,844
| Closed | -$14.8M | – | 4128 |
|
|
2017
Q4 | $14.8M | Buy |
608,844
+9,580
| +2% | +$184K | ﹤0.01% | 2635 |
|
|
2017
Q3 | $11.1M | Buy |
599,264
+113,970
| +23% | +$1.97M | ﹤0.01% | 2761 |
|
|
2017
Q2 | $8.04M | Buy |
485,294
+60,471
| +14% | +$841K | ﹤0.01% | 2880 |
|
|
2017
Q1 | $5.86M | Buy |
424,823
+185,833
| +78% | +$2.98M | ﹤0.01% | 3000 |
|
|
2016
Q4 | $4.53M | Buy |
238,990
+14,666
| +7% | +$281K | ﹤0.01% | 3099 |
|
|
2016
Q3 | $4.97M | Buy |
224,324
+8,929
| +4% | +$168K | ﹤0.01% | 3010 |
|
|
2016
Q2 | $3.94M | Buy |
215,395
+10,532
| +5% | +$181K | ﹤0.01% | 3088 |
|
|
2016
Q1 | $3.73M | Buy |
204,863
+19,237
| +10% | +$311K | ﹤0.01% | 3113 |
|
|
2015
Q4 | $3.13M | Buy |
185,626
+16,965
| +10% | +$288K | ﹤0.01% | 3213 |
|
|
2015
Q3 | $3.04M | Buy |
168,661
+59,907
| +55% | +$1.33M | ﹤0.01% | 3189 |
|
|
2015
Q2 | $2.81M | Buy |
108,754
+43,337
| +66% | +$1.1M | ﹤0.01% | 3278 |
|
|
2015
Q1 | $1.43M | Buy |
+65,417
| New | +$1.41M | ﹤0.01% | 3527 |
|
Vanguard Group's ENTL Position: Q1 2018 in Review
Vanguard Group sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 608,844 shares — an estimated $14.8M sold.
Vanguard Group first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $14.8M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.
- Vanguard Group reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
- Vanguard Group sold 608,844 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $14.8M.
- Vanguard Group first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
- Vanguard Group's Entellus Medical, Inc. Common Stock position peaked at $14.8M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.
Based on Vanguard Group's 13F filing for Q1 2018, filed 15 May 2018.